When is a drug too risky to stay on the market?
July 10, 2010 by Lynn
Filed under Menopause Treatment
When is a drug too risky to stay on the market?
The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on.
Read more on Muzi
Related posts:
- Diabetes drug debate puts focus on FDA safety rule
- Why Is The Question Of Palin Going Through Menopause Potentially Making A Risky President Off The Table?
- Who has info on the relation between in vitro fertilization treatment and breast cancer ?
- Study confirms combination hormone therapy increases risk of heart disease
- New scientific statement evaluates benefits and risks of menopausal hormone therapy
